Sviatlana Siankevich

Embion Technologies SA engages in the development of plant-based bioactives. Its rapid prototyping platform specializes in the efficient extraction of bioactive ingredients, through the use of underutilized industrial value-streams. Its product include PREMBION, a soluble bioactive compound with a unique composition of natural health benefits. The company was founded by Georgios Savoglidis, Sviatlana Siankevich, and Georgios Fengos in 2016 and is headquartered in Ecublens, Switzerland.

Embion Technologies SA engages in the development of plant-based bioactives. Its rapid prototyping platform specializes in the efficient extraction of bioactive ingredients, through the use of underutilized industrial value-streams. Its product include PREMBION, a soluble bioactive compound with a unique composition of natural health benefits. The company was founded by Georgios Savoglidis, Sviatlana Siankevich, and Georgios Fengos in 2016 and is headquartered in Ecublens, Switzerland.

Embion Technologies SA engages in the development of plant-based bioactives. Its rapid prototyping platform specializes in the efficient extraction of bioactive ingredients, through the use of underutilized industrial value-streams. Its product include PREMBION, a soluble bioactive compound with a unique composition of natural health benefits. The company was founded by Georgios Savoglidis, Sviatlana Siankevich, and Georgios Fengos in 2016 and is headquartered in Ecublens, Switzerland.

Embion Technologies SA engages in the development of plant-based bioactives. Its rapid prototyping platform specializes in the efficient extraction of bioactive ingredients, through the use of underutilized industrial value-streams. Its product include PREMBION, a soluble bioactive compound with a unique composition of natural health benefits. The company was founded by Georgios Savoglidis, Sviatlana Siankevich, and Georgios Fengos in 2016 and is headquartered in Ecublens, Switzerland.